11/12/2025
EyeCare Partners physicians are working to advance the science of vision care.
Michael Nordlund, M.D., Ph.D, (Cincinnati Eye Institute), Martin de la Presa, M.D., (Grene Vision Group) and Elizabeth Yeu, M.D., (Virginia Eye Consultants) recently contributed to the CLARA trial of AURN001, a regenerative cell therapy designed to restore corneal endothelial function.
The trial achieved all primary, secondary and exploratory goals, showing significant improvements in vision and quality of life, with strong safety and tolerability results. A pivotal U.S. Phase 3 study is planned for 2026.
These findings represent a meaningful step toward new, less invasive treatment options for patients with corneal endothelial disease and reflect EyeCare Partners’ commitment to support clinical innovation that improves lives.